$SIGA
SIGA TECHNOLOGIES INC Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924007487 Filed on March 12, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$25.43M	$116.5M	$139.9M
YoY Change	205.54%	925.53%	26.31%
Cost Of Revenue	$3.225M	$14.80M	$17.23M
YoY Change	180.42%	1579.63%	65.11%
Gross Profit	$22.20M	$101.7M	$122.7M
YoY Change	209.56%	870.5%	22.27%
Gross Profit Margin	87.32%	87.29%	87.69%
Selling, General & Admin	$7.876M	$7.382M	$22.04M
YoY Change	85.96%	25.64%	-37.23%
% of Gross Profit	35.47%	7.26%	17.97%
Research & Development	$3.053M	$2.618M	$16.43M
YoY Change	-39.49%	-59.14%	-27.07%
% of Gross Profit	13.75%	2.57%	13.39%
Depreciation & Amortization	$100.0K	$137.6K	$538.3K
YoY Change	0.0%	4.87%	7.66%
% of Gross Profit	0.45%	0.14%	0.44%
Operating Expenses	$10.93M	$10.00M	$38.47M
YoY Change	17.76%	-18.58%	-33.26%
Operating Profit	$11.28M	$91.68M	$84.22M
YoY Change	-634.81%	-5179.91%	97.24%
Interest Expense		$0.00	$0.00
YoY Change
% of Operating Profit		0.0%	0.0%
Other Income/Expense, Net	$1.942M	$1.191M	$4.156M
YoY Change	118.1%	75.87%	302.7%
Pretax Income	$13.22M	$92.87M	$87.78M
YoY Change	-1185.5%	-8336.93%	98.89%
Income Tax	$2.900M	$20.61M	$19.71M
% Of Pretax Income	21.94%	22.2%	22.45%
Net Earnings	$10.28M	$72.26M	$68.07M
YoY Change	-1219.23%	-9000.78%	100.76%
Net Earnings / Revenue	40.41%	62.03%	48.65%
Basic Earnings Per Share	$0.14		$0.95
Diluted Earnings Per Share	$0.14	$1.00	$0.95
COMMON SHARES
Basic Shares Outstanding	71.09M	71.09M	71.36M
Diluted Shares Outstanding	71.56M		71.68M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$143.9M	$150.1M	$150.1M
YoY Change	24.37%	51.98%	51.98%
Cash & Equivalents	$143.9M	$150.1M	$150.1M
Short-Term Investments
Other Short-Term Assets	$2.175M	$3.496M	$3.496M
YoY Change	11.05%	50.97%	50.97%
Inventory	$63.72M	$64.22M	$64.22M
Prepaid Expenses
Receivables	$18.13M	$21.13M	$21.13M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$227.9M	$239.0M	$239.0M
YoY Change	32.09%	28.64%	28.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.193M	$1.332M	$1.332M
YoY Change	-30.51%	-27.95%	-27.95%
Goodwill	$898.3K	$898.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.149M	$13.13M	$13.13M
YoY Change	5.3%	5099.71%	101.93%
Total Long-Term Assets	$15.25M	$15.36M	$15.36M
YoY Change	33.91%	66.08%	66.08%
TOTAL ASSETS
Total Short-Term Assets	$227.9M	$239.0M	$239.0M
Total Long-Term Assets	$15.25M	$15.36M	$15.36M
Total Assets	$243.1M	$254.4M	$254.4M
YoY Change	32.2%	30.41%	30.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.523M	$1.456M	$1.456M
YoY Change	121.38%	-56.6%	-56.6%
Accrued Expenses	$6.123M	$7.522M	$7.522M
YoY Change	-61.73%	-55.37%	50.59%
Deferred Revenue	$20.79M	$20.79M
YoY Change	97.58%	96.47%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$74.81M	$54.12M	$54.12M
YoY Change	304.9%	151.5%	151.5%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.343M	$3.376M	$3.376M
YoY Change	-0.34%	0.54%	0.54%
Total Long-Term Liabilities	$3.343M	$3.376M	$3.376M
YoY Change	-0.34%	0.54%	0.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$74.81M	$54.12M	$54.12M
Total Long-Term Liabilities	$3.343M	$3.376M	$3.376M
Total Liabilities	$78.16M	$57.49M	$57.49M
YoY Change	258.0%	131.12%	131.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$71.78M	-$38.94M
YoY Change	-0.69%	-38.96%
Common Stock	$236.8M	$235.8M
YoY Change	1.02%	0.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$165.0M	$196.9M	$196.9M
YoY Change
Total Liabilities & Shareholders Equity	$243.1M	$254.4M	$254.4M
YoY Change	32.2%	30.41%	30.41%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$10.28M	$72.26M	$68.07M
YoY Change	-1219.23%	-9000.78%	100.76%
Depreciation, Depletion And Amortization	$100.0K	$137.6K	$538.3K
YoY Change	0.0%	4.87%	7.66%
Cash From Operating Activities	-$6.118M	$79.03M	$94.80M
YoY Change	-125.03%	-1074.95%	127.82%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$1.690K	$21.69K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$1.690K	-$21.69K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid			$32.14M
YoY Change			-2.44%
Common Stock Issuance & Retirement, Net			-$11.07M
YoY Change			-185.13%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$159.0K	-2.420K	-43.42M
YoY Change	-97.9%	-99.92%	-5.52%
NET CHANGE
Cash From Operating Activities	-$6.118M	79.03M	94.80M
Cash From Investing Activities	$0.00	-1.690K	-21.69K
Cash From Financing Activities	-$159.0K	-2.420K	-43.42M
Net Change In Cash	-$6.277M	79.03M	51.36M
YoY Change	-137.17%	-821.16%	-1281.07%
FREE CASH FLOW
Cash From Operating Activities	-$6.118M	$79.03M	$94.80M
Capital Expenditures	$0.00	$1.690K	$21.69K
Free Cash Flow	-$6.118M	$79.03M	$94.78M
YoY Change	-125.03%	-1074.93%	127.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71091616
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71091616
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72675190
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72675190
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.45
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.45
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023	siga	Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants		pure
CY2022	siga	Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants	-0.002	pure
CY2021	siga	Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-23047
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3864870
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	31 East 62nd Street
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10065
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	672-9100
CY2023	dei	Security12b Title Security12bTitle	common stock, $.0001 par value
CY2023	dei	Trading Symbol TradingSymbol	SIGA
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	230952256	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71091616
CY2023	dei	Auditor Firm AuditorFirmId	238
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Florham Park, New Jersey
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	150145844	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98790622	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21130951	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45406960	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	64218337	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	39273090	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3496028	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2315672	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	238991160	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	185786344	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1331708	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1848314	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11048118	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6250385	usd
CY2023Q4	us-gaap	Goodwill Goodwill	898334	usd
CY2022Q4	us-gaap	Goodwill Goodwill	898334	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2083535	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	252546	usd
CY2023Q4	us-gaap	Assets Assets	254352855	usd
CY2022Q4	us-gaap	Assets Assets	195035923	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1456316	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3355268	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10181810	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6304061	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	20788720	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10548720	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	21690899	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1309672	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	54117745	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21517721	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	3376203	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	3358160	usd
CY2023Q4	us-gaap	Liabilities Liabilities	57493948	usd
CY2022Q4	us-gaap	Liabilities Liabilities	24875881	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7109	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7268	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	235795420	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	233957767	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38943622	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63804993	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	196858907	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	170160042	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	254352855	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195035923	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	139917220	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110775610	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	133670454	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17825090	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10432561	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16601880	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	170160042	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	68068826	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22043023	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35117241	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18033581	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16427942	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22525642	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9942194	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	56296055	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	68075444	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	44577655	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	83621165	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	42700166	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	89092799	usd
CY2023	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	0	usd
CY2022	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	400663	usd
CY2021	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	117770	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4155508	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1031903	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	101172	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	87776673	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44132732	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	89311741	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19707847	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10227926	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19860975	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	68068826	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	33904806	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	69450766	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.95
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71362209
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72929550
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75322194
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71679270
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73546501
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76402716
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	129793269	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	69450766	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	26021519	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	173918	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1265809	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174314407	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	33904806	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	13006331	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	6120778	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	12533	usd
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32940395	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1779310	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	11072511	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	214794	usd
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32135118	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2052462	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	196858907	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	68068826	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	33904806	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	69450766	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	538293	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	517643	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	522368	usd
CY2023	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-0	usd
CY2022	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	400663	usd
CY2021	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	117770	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2052462	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1779310	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1265809	usd
CY2023	siga	Inventory Write Down Net Of Credits InventoryWriteDownNetOfCredits	579239	usd
CY2022	siga	Inventory Write Down Net Of Credits InventoryWriteDownNetOfCredits	201472	usd
CY2021	siga	Inventory Write Down Net Of Credits InventoryWriteDownNetOfCredits	618771	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4797733	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3827778	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	121446	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-24276009	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-38243490	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	80310187	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	25524485	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19964183	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-136369	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3011346	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-171811	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-48963	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1996838	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1533804	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1470614	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	20381228	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-17897370	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	18287487	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	10240000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7348720	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	94799331	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41611062	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11494636	usd
CY2023	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	21686	usd
CY2022	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	-0	usd
CY2021	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	50620	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21686	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50620	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	214794	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12533	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	173918	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11072511	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13006331	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	26021519	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	32135118	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	32940395	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	-0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-43422423	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-45959259	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26195437	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	51355222	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4348197	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-14751421	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98790622	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103138819	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117890240	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150145844	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98790622	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103138819	usd
CY2023	siga	Noncash Lease Rightofuse Assets And Liabilities Assumed Net Of Deferred Rent Expense NoncashLeaseRightofuseAssetsAndLiabilitiesAssumedNetOfDeferredRentExpense	0	usd
CY2022	siga	Noncash Lease Rightofuse Assets And Liabilities Assumed Net Of Deferred Rent Expense NoncashLeaseRightofuseAssetsAndLiabilitiesAssumedNetOfDeferredRentExpense	0	usd
CY2021	siga	Noncash Lease Rightofuse Assets And Liabilities Assumed Net Of Deferred Rent Expense NoncashLeaseRightofuseAssetsAndLiabilitiesAssumedNetOfDeferredRentExpense	733715	usd
CY2023	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	0	usd
CY2022	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	6120778	usd
CY2021	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	0	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	87540	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023	siga	Income Taxes Paid Refund IncomeTaxesPaidRefund	3500873	usd
CY2022	siga	Income Taxes Paid Refund IncomeTaxesPaidRefund	31372881	usd
CY2021	siga	Income Taxes Paid Refund IncomeTaxesPaidRefund	1063744	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><b>Use of Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. The most significant estimates include the variables used in the calculation of reported amounts of revenue recognized over time, and the valuation of deferred tax assets. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary. Actual results could differ from these estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p>
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4200000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1000000	usd
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	100000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10181810	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6304061	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i><b>Reclassifications</b></i></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Certain reclassifications have been made to prior year amounts to conform to the current year's presentation.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b> </b></i></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Concentration of Credit Risk</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company has cash in bank accounts that exceeds the Federal Deposit Insurance Corporation insured limits. The Company has <em style="font: inherit;">not</em> experienced any losses on its cash accounts and <em style="font: inherit;">no</em> allowance has been provided for potential credit losses because management believes the potential for losses is remote.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Collection of all receivables from international government sales is coordinated through the International Promotion Agreement with Meridian (see <span style="text-decoration: underline; ">Note <em style="font: inherit;">3</em></span>), under which Meridian invoices and collects payments from international customers and remits such collections, less Meridian's fees, to the Company under a quarterly process specified in the International Promotion Agreement. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6521441	usd
CY2022	siga	Increase Decrease In Fair Value Of Warrant Liability IncreaseDecreaseInFairValueOfWarrantLiability	-400663	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6120778	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	10300000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	92100000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8061800	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6370581	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	53649859	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	27038845	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2506678	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5863664	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	64218337	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	39273090	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6914657	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6894863	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5582949	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5046549	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1331708	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1848314	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3300985	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	31160	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2792874	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2378035	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2659608	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1277779	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	445653	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	536997	usd
CY2023Q4	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	418681	usd
CY2022Q4	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	1551920	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	68068826	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	33904806	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	69450766	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	400663	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	117770	usd
CY2023	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	68068826	usd
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	33504143	usd
CY2021	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	69332996	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71362209
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72929550
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75322194
CY2023	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	317061
CY2022	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	616951
CY2021	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1080522
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71679270
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73546501
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76402716
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.95
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32660
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17388
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29873
CY2023Q4	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	620000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3818283	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	89947	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-86177	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-9495	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	31499	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4797733	usd
CY2021Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1800000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1300000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	123000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	375000	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	100000
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	23698658	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	13154619	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	19211782	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	792477	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	897285	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	513753	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	14445	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3800	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	13994	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24505580	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	14055704	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	19739529	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4711556	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3827778	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	121446	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19707847	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10227926	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19860975	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1194814	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1247826	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	777146	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	336333	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	666772	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	569290	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	7852	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	24532	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	506451	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	510058	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	34546	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	2256099	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	66011	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	6198455	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4194106	usd
CY2023Q4	siga	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	319074	usd
CY2022Q4	siga	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	443902	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	514150	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	380162	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12475359	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7772220	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	943903	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	985783	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11531456	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6786437	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	192130	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	192083	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	-0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	59727	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	291208	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	284242	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	11048118	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	6250385	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	42000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.016	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.005	pure
CY2023	siga	Effective Income Tax Rate Reconciliation Section162m Limitation Percent EffectiveIncomeTaxRateReconciliationSection162mLimitationPercent	0.004	pure
CY2022	siga	Effective Income Tax Rate Reconciliation Section162m Limitation Percent EffectiveIncomeTaxRateReconciliationSection162mLimitationPercent	0.007	pure
CY2021	siga	Effective Income Tax Rate Reconciliation Section162m Limitation Percent EffectiveIncomeTaxRateReconciliationSection162mLimitationPercent	0.005	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.225	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.222	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5103548	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5602587	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5591587	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	11000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	17096	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	68792	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	-0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	4842	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	430247	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5081610	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5103548	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5602587	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	5100000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	214000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	72000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	142000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-23000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	139917220	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110775610	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	133670454	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	700000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M13D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	622638	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	406994	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	409971	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	165916	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1605519	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	113642	usd
CY2023Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	14800000	usd

Files In Submission

Name	View Source	Status
0001437749-24-007487-index-headers.html	Edgar Link	pending
0001437749-24-007487-index.html	Edgar Link	pending
0001437749-24-007487.txt	Edgar Link	pending
0001437749-24-007487-xbrl.zip	Edgar Link	pending
ex_585431.htm	Edgar Link	pending
ex_585432.htm	Edgar Link	pending
ex_585433.htm	Edgar Link	pending
ex_585434.htm	Edgar Link	pending
ex_585435.htm	Edgar Link	pending
ex_598878.htm	Edgar Link	pending
ex_598879.htm	Edgar Link	pending
ex_625610.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20231231.xsd	Edgar Link	pending
siga20231231_10k.htm	Edgar Link	pending
siga-20231231_def.xml	Edgar Link	unprocessable
siga-20231231_lab.xml	Edgar Link	unprocessable
siga-20231231_pre.xml	Edgar Link	unprocessable
siga20231231_10k_htm.xml	Edgar Link	completed
siga-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA TECHNOLOGIES INC Stock $siga

2024 Q1 Form 10-K Financial Statement

#000143774924007487 Filed on March 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA TECHNOLOGIES INC Stock $siga

2024 Q1 Form 10-K Financial Statement

#000143774924007487 Filed on March 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA TECHNOLOGIES INC Stock $siga